1. All Products
  2. PHYG - Hygiene
  3. IMMUNOGLOBULIN HUMAN ANTIRABIES, 300IU/ml, 5ml, vial
Public Pricelist

IMMUNOGLOBULIN HUMAN ANTIRABIES, 300IU/ml, 5ml, vial

https://medicalguidelines.msf.org/en/node/975
https://unicat.msf.org/cat/product/77039
STD DVACIMHR3V5

Valid Article

The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
to delete - to delete
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J06BB05
Anatomical Therapeutic Chemical Classification according to WHOCC
E
The order of this product needs to be justified and is only acceptable under certain conditions.
0208
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
https://unicat.msf.org/web/image/product.template/569228/image_1920?unique=e47b90a

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

IMMUNOGLOBULIN HUMAN ANTIRABIES

Therapeutic Action

Human Rabies Immunoglobulin (HRIG) mainly contains immunoglobulin G (IgG) with a high concentration of antibodies against the rabies virus.

Indications

Prevention of rabies following Category III exposure, except in patients who have completed a full course of pre-exposure prophylaxis against rabies

Prevention of rabies following Category II and III exposures in immunocompromised patients

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Must be given by infiltration into and around the wound.

Treatment should be started as soon as possible after exposure, but should not be denied to an exposed person regardless of the time elapsed since exposure.

In general, administered in combination with the rabies vaccine.

The two presentations (1 or 5 ml) are interchangeable, depending on availability when ordering.

Precautions for Use

As with all injectable vaccines and/or immunoglobulins, appropriate medical treatment should always be readily available in case of rare anaphylactic reactions following the administration of the product.

Storage

  • Keep refrigerated between 2ºC and 8ºC - Protect from sunlight
  • Do not freeze.

(Cf Introduction: Thermosensitive products)